
Neurogene Inc.
USD26.22
+0.08 (+0.31%)
CEO
Rachel L. McMinn
IPO Date
2014-03-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$26.89
Prev. Close
$26.14
Day Low
$25.92
Day High
$27.02
52W Low
$14.65
52W High
$37.27
Market Cap
$0.41B
Volume
0.08M
| 31 Oct 2025 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 9 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 12 Jun 2025 | BMO Capital | Outperform | Outperform | maintain |
| 20 May 2025 | BMO Capital | Outperform | Outperform | maintain |
| 16 May 2025 | Baird | Outperform | Neutral | downgrade |
| 13 May 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 14 Apr 2025 | BMO Capital | Outperform | Outperform | maintain |